Form 4: Zeo ScientifiX Director Leathem S. Stearn Acquires Stock Options

Director Leathem S. Stearn reports acquisition of stock options in Zeo ScientifiX, Inc.

Summary

• On May 8, 2025, Leathem S. Stearn, a director of Zeo ScientifiX, Inc., acquired stock options to purchase 10,000 shares of the company's common stock.
• 5,000 of these options vested immediately, while the remaining 5,000 vest as to 2,000 shares as of the grant date and will vest as to the remaining 3,000 shares on September 23, 2025.
• The exercise price for the options is $2.86 per share, and they expire on May 8, 2030.
• The options were granted under the company's 2021 Equity Incentive Plan.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, suggesting a neutral to slightly positive sentiment as it aligns management interests with shareholders.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule may incentivize the director to remain with the company.

Future Outlook

NA

Industry Context

Stock option grants are a common form of executive compensation in the technology and science industries, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in publicly traded companies.
• The vesting schedule and exercise price are within the range of industry norms for similar-sized companies.

Stakeholder Impact

• The stock option grant could potentially increase shareholder value if the director's performance leads to an increase in the company's stock price.

Key Dates

Keywords

stock options, director, ZEOX, Zeo ScientifiX, beneficial ownership, Form 4, Stearn